• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION EMBOZENE MICROSPHERES; EMBOLIC DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION EMBOZENE MICROSPHERES; EMBOLIC DEVICE Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Fatigue (1849); Hemorrhage/Bleeding (1888); Nausea (1970)
Event Date 07/17/2020
Event Type  Death  
Manufacturer Narrative
Date of event: event date not provided and publication date of journal article was used.Sebastian, nikhil t., et al."a pilot trial evaluating stereotactic body radiation therapy to induce hyperemia in combination with transarterial chemoembolization for hepatocellular carcinoma." international journal of radiation oncology* biology* physics 108.5 (2020): 1276-1283.
 
Event Description
It was reported a subject passed away following transarterial chemoembolization (tace) via a journal article.Sixteen patients were enrolled the study.13 patients received single-fraction stereotactic body radiation therapy (sbrt) followed by tace within 24 hours.Median follow-up was 15.3 months.The most common toxicities were fatigue (46.2%), abdominal pain (38.5%), and nausea (38.5%).Crude rates of grade 1 or higher and grade 2 or higher toxicity were 85% and 38%, respectively.There were no grade 3 or 4 toxicities.One patient in cohort 2 died of intraperitoneal hemorrhage 4 days after tace (grade 5 toxicity), which was probably related to protocol therapy.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EMBOZENE MICROSPHERES
Type of Device
EMBOLIC DEVICE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key12158176
MDR Text Key261213094
Report Number2134265-2021-08849
Device Sequence Number1
Product Code NAJ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Type of Report Initial
Report Date 07/13/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/13/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received06/21/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
-
-